Business Wire

4D pharma Announces FDA Clearance of IND Application for Live Biotherapeutics MRx0005 and MRx0029 for the Treatment of Parkinson’s Disease

LEEDS, England--(BUSINESS WIRE)--4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from ...
pharmaphorum

4D pharma’s live bacteria show promise in multiple sclerosis

A UK company specialising in using live bacteria as medicine says it has had promising early-stage results in treating multiple sclerosis (MS). 4D pharma is focusing on the development of live ...